Shopping Cart 0
Cart Subtotal
AED 0

Global Prostate Cancer Medicine Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 12772

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 19157

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 25543
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Prostate cancer is the development of cancer in the prostate, a gland in the male reproductive system. This cancer develops slowly, with no early detectable symptoms for many years. The precise cause of prostate cancer is unknown; however, factors such as obesity, high calcium diet, lack of exercise, ethnicity (African American men), and old age contribute to its occurrence.

Scope of the Report:

This report studies the Prostate Cancer Medicine market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Prostate Cancer Medicine market by product type and applications/end industries.

The global Prostate Cancer Medicine market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Prostate Cancer Medicine.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

AstraZeneca plc

Active Biotech

Bristol Myers-Squibb

Teva Pharmaceuticals Industries Ltd.

Johnson & Johnson

Pfizer Inc.

Bayer AG

Abbott Laboratories

Astellas Pharma Inc.

Roche Holding AG

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

LHRH Antagonists

LHRH Analogs

Antiandrogens

Pipeline Drugs for Hormonal Therapy

Market Segment by Applications, can be divided into

Hospitals

Other

READ MORE

Table Of Content

Scope

Table of Contents

1 Prostate Cancer Medicine Market Overview

1.1 Product Overview and Scope of Prostate Cancer Medicine

1.2 Classification of Prostate Cancer Medicine by Types

1.2.1 Global Prostate Cancer Medicine Revenue Comparison by Types (2017-2023)

1.2.2 Global Prostate Cancer Medicine Revenue Market Share by Types in 2017

1.2.3 LHRH Antagonists

1.2.4 LHRH Analogs

1.2.5 Antiandrogens

1.2.6 Pipeline Drugs for Hormonal Therapy

1.3 Global Prostate Cancer Medicine Market by Application

1.3.1 Global Prostate Cancer Medicine Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Hospitals

1.3.3 Other

1.4 Global Prostate Cancer Medicine Market by Regions

1.4.1 Global Prostate Cancer Medicine Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Prostate Cancer Medicine Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Prostate Cancer Medicine Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Prostate Cancer Medicine Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Prostate Cancer Medicine Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Prostate Cancer Medicine Status and Prospect (2013-2023)

1.5 Global Market Size of Prostate Cancer Medicine (2013-2023)

2 Manufacturers Profiles

2.1 AstraZeneca plc

2.1.1 Business Overview

2.1.2 Prostate Cancer Medicine Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 AstraZeneca plc Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2016-2017)

2.2 Active Biotech

2.2.1 Business Overview

2.2.2 Prostate Cancer Medicine Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Active Biotech Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2016-2017)

2.3 Bristol Myers-Squibb

2.3.1 Business Overview

2.3.2 Prostate Cancer Medicine Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Bristol Myers-Squibb Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2016-2017)

2.4 Teva Pharmaceuticals Industries Ltd.

2.4.1 Business Overview

2.4.2 Prostate Cancer Medicine Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2016-2017)

2.5 Johnson & Johnson

2.5.1 Business Overview

2.5.2 Prostate Cancer Medicine Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Johnson & Johnson Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2016-2017)

2.6 Pfizer Inc.

2.6.1 Business Overview

2.6.2 Prostate Cancer Medicine Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Pfizer Inc. Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2016-2017)

2.7 Bayer AG

2.7.1 Business Overview

2.7.2 Prostate Cancer Medicine Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Bayer AG Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2016-2017)

2.8 Abbott Laboratories

2.8.1 Business Overview

2.8.2 Prostate Cancer Medicine Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Abbott Laboratories Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2016-2017)

2.9 Astellas Pharma Inc.

2.9.1 Business Overview

2.9.2 Prostate Cancer Medicine Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Astellas Pharma Inc. Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2016-2017)

2.10 Roche Holding AG

2.10.1 Business Overview

2.10.2 Prostate Cancer Medicine Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Roche Holding AG Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2016-2017)

3 Global Prostate Cancer Medicine Market Competition, by Players

3.1 Global Prostate Cancer Medicine Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Prostate Cancer Medicine Players Market Share

3.2.2 Top 10 Prostate Cancer Medicine Players Market Share

3.3 Market Competition Trend

4 Global Prostate Cancer Medicine Market Size by Regions

4.1 Global Prostate Cancer Medicine Revenue and Market Share by Regions

4.2 North America Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

4.3 Europe Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

4.5 South America Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

5 North America Prostate Cancer Medicine Revenue by Countries

5.1 North America Prostate Cancer Medicine Revenue by Countries (2013-2018)

5.2 USA Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

5.3 Canada Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

5.4 Mexico Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

6 Europe Prostate Cancer Medicine Revenue by Countries

6.1 Europe Prostate Cancer Medicine Revenue by Countries (2013-2018)

6.2 Germany Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

6.3 UK Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

6.4 France Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

6.5 Russia Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

6.6 Italy Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Prostate Cancer Medicine Revenue by Countries

7.1 Asia-Pacific Prostate Cancer Medicine Revenue by Countries (2013-2018)

7.2 China Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

7.3 Japan Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

7.4 Korea Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

7.5 India Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

8 South America Prostate Cancer Medicine Revenue by Countries

8.1 South America Prostate Cancer Medicine Revenue by Countries (2013-2018)

8.2 Brazil Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

8.3 Argentina Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

8.4 Colombia Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Prostate Cancer Medicine by Countries

9.1 Middle East and Africa Prostate Cancer Medicine Revenue by Countries (2013-2018)

9.2 Saudi Arabia Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

9.3 UAE Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

9.4 Egypt Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

9.5 Nigeria Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

9.6 South Africa Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

10 Global Prostate Cancer Medicine Market Segment by Type

10.1 Global Prostate Cancer Medicine Revenue and Market Share by Type (2013-2018)

10.2 Global Prostate Cancer Medicine Market Forecast by Type (2018-2023)

10.3 LHRH Antagonists Revenue Growth Rate (2013-2023)

10.4 LHRH Analogs Revenue Growth Rate (2013-2023)

10.5 Antiandrogens Revenue Growth Rate (2013-2023)

10.6 Pipeline Drugs for Hormonal Therapy Revenue Growth Rate (2013-2023)

11 Global Prostate Cancer Medicine Market Segment by Application

11.1 Global Prostate Cancer Medicine Revenue Market Share by Application (2013-2018)

11.2 Prostate Cancer Medicine Market Forecast by Application (2018-2023)

11.3 Hospitals Revenue Growth (2013-2018)

11.4 Other Revenue Growth (2013-2018)

12 Global Prostate Cancer Medicine Market Size Forecast (2018-2023)

12.1 Global Prostate Cancer Medicine Market Size Forecast (2018-2023)

12.2 Global Prostate Cancer Medicine Market Forecast by Regions (2018-2023)

12.3 North America Prostate Cancer Medicine Revenue Market Forecast (2018-2023)

12.4 Europe Prostate Cancer Medicine Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Prostate Cancer Medicine Revenue Market Forecast (2018-2023)

12.6 South America Prostate Cancer Medicine Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Prostate Cancer Medicine Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source


List Of Table

List of Tables and Figures

Figure Prostate Cancer Medicine Picture

Table Product Specifications of Prostate Cancer Medicine

Table Global Prostate Cancer Medicine and Revenue (Million USD) Market Split by Product Type

Figure Global Prostate Cancer Medicine Revenue Market Share by Types in 2017

Figure LHRH Antagonists Picture

Figure LHRH Analogs Picture

Figure Antiandrogens Picture

Figure Pipeline Drugs for Hormonal Therapy Picture

Table Global Prostate Cancer Medicine Revenue (Million USD) by Application (2013-2023)

Figure Prostate Cancer Medicine Revenue Market Share by Applications in 2017

Figure Hospitals Picture

Figure Other Picture

Table Global Market Prostate Cancer Medicine Revenue (Million USD) Comparison by Regions 2013-2023

Figure North America Prostate Cancer Medicine Revenue (Million USD) and Growth Rate (2013-2023)

Figure Europe Prostate Cancer Medicine Revenue (Million USD) and Growth Rate (2013-2023)

Figure Asia-Pacific Prostate Cancer Medicine Revenue (Million USD) and Growth Rate (2013-2023)

Figure South America Prostate Cancer Medicine Revenue (Million USD) and Growth Rate (2013-2023)

Figure Middle East and Africa Prostate Cancer Medicine Revenue (Million USD) and Growth Rate (2013-2023)

Figure Global Prostate Cancer Medicine Revenue (Million USD) and Growth Rate (2013-2023)

Table AstraZeneca plc Basic Information, Manufacturing Base and Competitors

Table AstraZeneca plc Prostate Cancer Medicine Type and Applications

Table AstraZeneca plc Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2016-2017)

Table Active Biotech Basic Information, Manufacturing Base and Competitors

Table Active Biotech Prostate Cancer Medicine Type and Applications

Table Active Biotech Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2016-2017)

Table Bristol Myers-Squibb Basic Information, Manufacturing Base and Competitors

Table Bristol Myers-Squibb Prostate Cancer Medicine Type and Applications

Table Bristol Myers-Squibb Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2016-2017)

Table Teva Pharmaceuticals Industries Ltd. Basic Information, Manufacturing Base and Competitors

Table Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Type and Applications

Table Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2016-2017)

Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors

Table Johnson & Johnson Prostate Cancer Medicine Type and Applications

Table Johnson & Johnson Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2016-2017)

Table Pfizer Inc. Basic Information, Manufacturing Base and Competitors

Table Pfizer Inc. Prostate Cancer Medicine Type and Applications

Table Pfizer Inc. Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2016-2017)

Table Bayer AG Basic Information, Manufacturing Base and Competitors

Table Bayer AG Prostate Cancer Medicine Type and Applications

Table Bayer AG Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2016-2017)

Table Abbott Laboratories Basic Information, Manufacturing Base and Competitors

Table Abbott Laboratories Prostate Cancer Medicine Type and Applications

Table Abbott Laboratories Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2016-2017)

Table Astellas Pharma Inc. Basic Information, Manufacturing Base and Competitors

Table Astellas Pharma Inc. Prostate Cancer Medicine Type and Applications

Table Astellas Pharma Inc. Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2016-2017)

Table Roche Holding AG Basic Information, Manufacturing Base and Competitors

Table Roche Holding AG Prostate Cancer Medicine Type and Applications

Table Roche Holding AG Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2016-2017)

Table Global Prostate Cancer Medicine Revenue (Million USD) by Players (2013-2018)

Table Global Prostate Cancer Medicine Revenue Share by Players (2013-2018)

Figure Global Prostate Cancer Medicine Revenue Share by Players in 2016

Figure Global Prostate Cancer Medicine Revenue Share by Players in 2017

Figure Global Top 5 Players Prostate Cancer Medicine Revenue Market Share in 2017

Figure Global Top 10 Players Prostate Cancer Medicine Revenue Market Share in 2017

Figure Global Prostate Cancer Medicine Revenue (Million USD) and Growth Rate (%) (2013-2018)

Table Global Prostate Cancer Medicine Revenue (Million USD) by Regions (2013-2018)

Table Global Prostate Cancer Medicine Revenue Market Share by Regions (2013-2018)

Figure Global Prostate Cancer Medicine Revenue Market Share by Regions (2013-2018)

Figure Global Prostate Cancer Medicine Revenue Market Share by Regions in 2017

Figure North America Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

Figure Europe Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

Figure Asia-Pacific Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

Figure South America Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

Figure Middle East and Africa Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

Table North America Prostate Cancer Medicine Revenue by Countries (2013-2018)

Table North America Prostate Cancer Medicine Revenue Market Share by Countries (2013-2018)

Figure North America Prostate Cancer Medicine Revenue Market Share by Countries (2013-2018)

Figure North America Prostate Cancer Medicine Revenue Market Share by Countries in 2017

Figure USA Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

Figure Canada Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

Figure Mexico Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

Table Europe Prostate Cancer Medicine Revenue (Million USD) by Countries (2013-2018)

Figure Europe Prostate Cancer Medicine Revenue Market Share by Countries (2013-2018)

Figure Europe Prostate Cancer Medicine Revenue Market Share by Countries in 2017

Figure Germany Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

Figure UK Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

Figure France Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

Figure Russia Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

Figure Italy Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Prostate Cancer Medicine Revenue (Million USD) by Countries (2013-2018)

Figure Asia-Pacific Prostate Cancer Medicine Revenue Market Share by Countries (2013-2018)

Figure Asia-Pacific Prostate Cancer Medicine Revenue Market Share by Countries in 2017

Figure China Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

Figure Japan Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

Figure Korea Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

Figure India Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

Figure Southeast Asia Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

Table South America Prostate Cancer Medicine Revenue by Countries (2013-2018)

Table South America Prostate Cancer Medicine Revenue Market Share by Countries (2013-2018)

Figure South America Prostate Cancer Medicine Revenue Market Share by Countries (2013-2018)

Figure South America Prostate Cancer Medicine Revenue Market Share by Countries in 2017

Figure Brazil Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

Figure Argentina Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

Figure Colombia Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Prostate Cancer Medicine Revenue (Million USD) by Countries (2013-2018)

Table Middle East and Africa Prostate Cancer Medicine Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Prostate Cancer Medicine Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Prostate Cancer Medicine Revenue Market Share by Countries in 2017

Figure Saudi Arabia Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

Figure UAE Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

Figure Egypt Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

Figure Nigeria Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

Figure South Africa Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

Table Global Prostate Cancer Medicine Revenue (Million USD) by Type (2013-2018)

Table Global Prostate Cancer Medicine Revenue Share by Type (2013-2018)

Figure Global Prostate Cancer Medicine Revenue Share by Type (2013-2018)

Figure Global Prostate Cancer Medicine Revenue Share by Type in 2017

Table Global Prostate Cancer Medicine Revenue Forecast by Type (2018-2023)

Figure Global Prostate Cancer Medicine Market Share Forecast by Type (2018-2023)

Figure Global LHRH Antagonists Revenue Growth Rate (2013-2018)

Figure Global LHRH Analogs Revenue Growth Rate (2013-2018)

Figure Global Antiandrogens Revenue Growth Rate (2013-2018)

Figure Global Pipeline Drugs for Hormonal Therapy Revenue Growth Rate (2013-2018)

Table Global Prostate Cancer Medicine Revenue by Application (2013-2018)

Table Global Prostate Cancer Medicine Revenue Share by Application (2013-2018)

Figure Global Prostate Cancer Medicine Revenue Share by Application (2013-2018)

Figure Global Prostate Cancer Medicine Revenue Share by Application in 2017

Table Global Prostate Cancer Medicine Revenue Forecast by Application (2018-2023)

Figure Global Prostate Cancer Medicine Market Share Forecast by Application (2018-2023)

Figure Global Hospitals Revenue Growth Rate (2013-2018)

Figure Global Other Revenue Growth Rate (2013-2018)

Figure Global Prostate Cancer Medicine Revenue (Million USD) and Growth Rate Forecast (2018 -2023)

Table Global Prostate Cancer Medicine Revenue (Million USD) Forecast by Regions (2018-2023)

Figure Global Prostate Cancer Medicine Revenue Market Share Forecast by Regions (2018-2023)

Figure North America Prostate Cancer Medicine Revenue Market Forecast (2018-2023)

Figure Europe Prostate Cancer Medicine Revenue Market Forecast (2018-2023)

Figure Asia-Pacific Prostate Cancer Medicine Revenue Market Forecast (2018-2023)

Figure South America Prostate Cancer Medicine Revenue Market Forecast (2018-2023)

Figure Middle East and Africa Prostate Cancer Medicine Revenue Market Forecast (2018-2023)

Licence Rights

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

AstraZeneca plc

Active Biotech

Bristol Myers-Squibb

Teva Pharmaceuticals Industries Ltd.

Johnson & Johnson

Pfizer Inc.

Bayer AG

Abbott Laboratories

Astellas Pharma Inc.

Roche Holding AG

Prostate cancer is the development of cancer in the prostate, a gland in the male reproductive system. This cancer develops slowly, with no early detectable symptoms for many years. The precise cause of prostate cancer is unknown; however, factors such as obesity, high calcium diet, lack of exercise, ethnicity (African American men), and old age contribute to its occurrence.

Scope of the Report:

This report studies the Prostate Cancer Medicine market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Prostate Cancer Medicine market by product type and applications/end industries.

The global Prostate Cancer Medicine market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Prostate Cancer Medicine.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

AstraZeneca plc

Active Biotech

Bristol Myers-Squibb

Teva Pharmaceuticals Industries Ltd.

Johnson & Johnson

Pfizer Inc.

Bayer AG

Abbott Laboratories

Astellas Pharma Inc.

Roche Holding AG

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

LHRH Antagonists

LHRH Analogs

Antiandrogens

Pipeline Drugs for Hormonal Therapy

Market Segment by Applications, can be divided into

Hospitals

Other

READ MORE

Scope

Table of Contents

1 Prostate Cancer Medicine Market Overview

1.1 Product Overview and Scope of Prostate Cancer Medicine

1.2 Classification of Prostate Cancer Medicine by Types

1.2.1 Global Prostate Cancer Medicine Revenue Comparison by Types (2017-2023)

1.2.2 Global Prostate Cancer Medicine Revenue Market Share by Types in 2017

1.2.3 LHRH Antagonists

1.2.4 LHRH Analogs

1.2.5 Antiandrogens

1.2.6 Pipeline Drugs for Hormonal Therapy

1.3 Global Prostate Cancer Medicine Market by Application

1.3.1 Global Prostate Cancer Medicine Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Hospitals

1.3.3 Other

1.4 Global Prostate Cancer Medicine Market by Regions

1.4.1 Global Prostate Cancer Medicine Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Prostate Cancer Medicine Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Prostate Cancer Medicine Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Prostate Cancer Medicine Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Prostate Cancer Medicine Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Prostate Cancer Medicine Status and Prospect (2013-2023)

1.5 Global Market Size of Prostate Cancer Medicine (2013-2023)

2 Manufacturers Profiles

2.1 AstraZeneca plc

2.1.1 Business Overview

2.1.2 Prostate Cancer Medicine Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 AstraZeneca plc Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2016-2017)

2.2 Active Biotech

2.2.1 Business Overview

2.2.2 Prostate Cancer Medicine Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Active Biotech Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2016-2017)

2.3 Bristol Myers-Squibb

2.3.1 Business Overview

2.3.2 Prostate Cancer Medicine Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Bristol Myers-Squibb Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2016-2017)

2.4 Teva Pharmaceuticals Industries Ltd.

2.4.1 Business Overview

2.4.2 Prostate Cancer Medicine Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2016-2017)

2.5 Johnson & Johnson

2.5.1 Business Overview

2.5.2 Prostate Cancer Medicine Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Johnson & Johnson Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2016-2017)

2.6 Pfizer Inc.

2.6.1 Business Overview

2.6.2 Prostate Cancer Medicine Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Pfizer Inc. Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2016-2017)

2.7 Bayer AG

2.7.1 Business Overview

2.7.2 Prostate Cancer Medicine Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Bayer AG Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2016-2017)

2.8 Abbott Laboratories

2.8.1 Business Overview

2.8.2 Prostate Cancer Medicine Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Abbott Laboratories Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2016-2017)

2.9 Astellas Pharma Inc.

2.9.1 Business Overview

2.9.2 Prostate Cancer Medicine Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Astellas Pharma Inc. Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2016-2017)

2.10 Roche Holding AG

2.10.1 Business Overview

2.10.2 Prostate Cancer Medicine Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Roche Holding AG Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2016-2017)

3 Global Prostate Cancer Medicine Market Competition, by Players

3.1 Global Prostate Cancer Medicine Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Prostate Cancer Medicine Players Market Share

3.2.2 Top 10 Prostate Cancer Medicine Players Market Share

3.3 Market Competition Trend

4 Global Prostate Cancer Medicine Market Size by Regions

4.1 Global Prostate Cancer Medicine Revenue and Market Share by Regions

4.2 North America Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

4.3 Europe Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

4.5 South America Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

5 North America Prostate Cancer Medicine Revenue by Countries

5.1 North America Prostate Cancer Medicine Revenue by Countries (2013-2018)

5.2 USA Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

5.3 Canada Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

5.4 Mexico Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

6 Europe Prostate Cancer Medicine Revenue by Countries

6.1 Europe Prostate Cancer Medicine Revenue by Countries (2013-2018)

6.2 Germany Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

6.3 UK Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

6.4 France Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

6.5 Russia Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

6.6 Italy Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Prostate Cancer Medicine Revenue by Countries

7.1 Asia-Pacific Prostate Cancer Medicine Revenue by Countries (2013-2018)

7.2 China Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

7.3 Japan Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

7.4 Korea Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

7.5 India Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

8 South America Prostate Cancer Medicine Revenue by Countries

8.1 South America Prostate Cancer Medicine Revenue by Countries (2013-2018)

8.2 Brazil Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

8.3 Argentina Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

8.4 Colombia Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Prostate Cancer Medicine by Countries

9.1 Middle East and Africa Prostate Cancer Medicine Revenue by Countries (2013-2018)

9.2 Saudi Arabia Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

9.3 UAE Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

9.4 Egypt Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

9.5 Nigeria Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

9.6 South Africa Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

10 Global Prostate Cancer Medicine Market Segment by Type

10.1 Global Prostate Cancer Medicine Revenue and Market Share by Type (2013-2018)

10.2 Global Prostate Cancer Medicine Market Forecast by Type (2018-2023)

10.3 LHRH Antagonists Revenue Growth Rate (2013-2023)

10.4 LHRH Analogs Revenue Growth Rate (2013-2023)

10.5 Antiandrogens Revenue Growth Rate (2013-2023)

10.6 Pipeline Drugs for Hormonal Therapy Revenue Growth Rate (2013-2023)

11 Global Prostate Cancer Medicine Market Segment by Application

11.1 Global Prostate Cancer Medicine Revenue Market Share by Application (2013-2018)

11.2 Prostate Cancer Medicine Market Forecast by Application (2018-2023)

11.3 Hospitals Revenue Growth (2013-2018)

11.4 Other Revenue Growth (2013-2018)

12 Global Prostate Cancer Medicine Market Size Forecast (2018-2023)

12.1 Global Prostate Cancer Medicine Market Size Forecast (2018-2023)

12.2 Global Prostate Cancer Medicine Market Forecast by Regions (2018-2023)

12.3 North America Prostate Cancer Medicine Revenue Market Forecast (2018-2023)

12.4 Europe Prostate Cancer Medicine Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Prostate Cancer Medicine Revenue Market Forecast (2018-2023)

12.6 South America Prostate Cancer Medicine Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Prostate Cancer Medicine Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source


List Of Table

List of Tables and Figures

Figure Prostate Cancer Medicine Picture

Table Product Specifications of Prostate Cancer Medicine

Table Global Prostate Cancer Medicine and Revenue (Million USD) Market Split by Product Type

Figure Global Prostate Cancer Medicine Revenue Market Share by Types in 2017

Figure LHRH Antagonists Picture

Figure LHRH Analogs Picture

Figure Antiandrogens Picture

Figure Pipeline Drugs for Hormonal Therapy Picture

Table Global Prostate Cancer Medicine Revenue (Million USD) by Application (2013-2023)

Figure Prostate Cancer Medicine Revenue Market Share by Applications in 2017

Figure Hospitals Picture

Figure Other Picture

Table Global Market Prostate Cancer Medicine Revenue (Million USD) Comparison by Regions 2013-2023

Figure North America Prostate Cancer Medicine Revenue (Million USD) and Growth Rate (2013-2023)

Figure Europe Prostate Cancer Medicine Revenue (Million USD) and Growth Rate (2013-2023)

Figure Asia-Pacific Prostate Cancer Medicine Revenue (Million USD) and Growth Rate (2013-2023)

Figure South America Prostate Cancer Medicine Revenue (Million USD) and Growth Rate (2013-2023)

Figure Middle East and Africa Prostate Cancer Medicine Revenue (Million USD) and Growth Rate (2013-2023)

Figure Global Prostate Cancer Medicine Revenue (Million USD) and Growth Rate (2013-2023)

Table AstraZeneca plc Basic Information, Manufacturing Base and Competitors

Table AstraZeneca plc Prostate Cancer Medicine Type and Applications

Table AstraZeneca plc Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2016-2017)

Table Active Biotech Basic Information, Manufacturing Base and Competitors

Table Active Biotech Prostate Cancer Medicine Type and Applications

Table Active Biotech Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2016-2017)

Table Bristol Myers-Squibb Basic Information, Manufacturing Base and Competitors

Table Bristol Myers-Squibb Prostate Cancer Medicine Type and Applications

Table Bristol Myers-Squibb Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2016-2017)

Table Teva Pharmaceuticals Industries Ltd. Basic Information, Manufacturing Base and Competitors

Table Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Type and Applications

Table Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2016-2017)

Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors

Table Johnson & Johnson Prostate Cancer Medicine Type and Applications

Table Johnson & Johnson Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2016-2017)

Table Pfizer Inc. Basic Information, Manufacturing Base and Competitors

Table Pfizer Inc. Prostate Cancer Medicine Type and Applications

Table Pfizer Inc. Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2016-2017)

Table Bayer AG Basic Information, Manufacturing Base and Competitors

Table Bayer AG Prostate Cancer Medicine Type and Applications

Table Bayer AG Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2016-2017)

Table Abbott Laboratories Basic Information, Manufacturing Base and Competitors

Table Abbott Laboratories Prostate Cancer Medicine Type and Applications

Table Abbott Laboratories Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2016-2017)

Table Astellas Pharma Inc. Basic Information, Manufacturing Base and Competitors

Table Astellas Pharma Inc. Prostate Cancer Medicine Type and Applications

Table Astellas Pharma Inc. Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2016-2017)

Table Roche Holding AG Basic Information, Manufacturing Base and Competitors

Table Roche Holding AG Prostate Cancer Medicine Type and Applications

Table Roche Holding AG Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2016-2017)

Table Global Prostate Cancer Medicine Revenue (Million USD) by Players (2013-2018)

Table Global Prostate Cancer Medicine Revenue Share by Players (2013-2018)

Figure Global Prostate Cancer Medicine Revenue Share by Players in 2016

Figure Global Prostate Cancer Medicine Revenue Share by Players in 2017

Figure Global Top 5 Players Prostate Cancer Medicine Revenue Market Share in 2017

Figure Global Top 10 Players Prostate Cancer Medicine Revenue Market Share in 2017

Figure Global Prostate Cancer Medicine Revenue (Million USD) and Growth Rate (%) (2013-2018)

Table Global Prostate Cancer Medicine Revenue (Million USD) by Regions (2013-2018)

Table Global Prostate Cancer Medicine Revenue Market Share by Regions (2013-2018)

Figure Global Prostate Cancer Medicine Revenue Market Share by Regions (2013-2018)

Figure Global Prostate Cancer Medicine Revenue Market Share by Regions in 2017

Figure North America Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

Figure Europe Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

Figure Asia-Pacific Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

Figure South America Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

Figure Middle East and Africa Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

Table North America Prostate Cancer Medicine Revenue by Countries (2013-2018)

Table North America Prostate Cancer Medicine Revenue Market Share by Countries (2013-2018)

Figure North America Prostate Cancer Medicine Revenue Market Share by Countries (2013-2018)

Figure North America Prostate Cancer Medicine Revenue Market Share by Countries in 2017

Figure USA Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

Figure Canada Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

Figure Mexico Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

Table Europe Prostate Cancer Medicine Revenue (Million USD) by Countries (2013-2018)

Figure Europe Prostate Cancer Medicine Revenue Market Share by Countries (2013-2018)

Figure Europe Prostate Cancer Medicine Revenue Market Share by Countries in 2017

Figure Germany Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

Figure UK Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

Figure France Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

Figure Russia Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

Figure Italy Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Prostate Cancer Medicine Revenue (Million USD) by Countries (2013-2018)

Figure Asia-Pacific Prostate Cancer Medicine Revenue Market Share by Countries (2013-2018)

Figure Asia-Pacific Prostate Cancer Medicine Revenue Market Share by Countries in 2017

Figure China Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

Figure Japan Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

Figure Korea Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

Figure India Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

Figure Southeast Asia Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

Table South America Prostate Cancer Medicine Revenue by Countries (2013-2018)

Table South America Prostate Cancer Medicine Revenue Market Share by Countries (2013-2018)

Figure South America Prostate Cancer Medicine Revenue Market Share by Countries (2013-2018)

Figure South America Prostate Cancer Medicine Revenue Market Share by Countries in 2017

Figure Brazil Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

Figure Argentina Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

Figure Colombia Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Prostate Cancer Medicine Revenue (Million USD) by Countries (2013-2018)

Table Middle East and Africa Prostate Cancer Medicine Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Prostate Cancer Medicine Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Prostate Cancer Medicine Revenue Market Share by Countries in 2017

Figure Saudi Arabia Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

Figure UAE Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

Figure Egypt Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

Figure Nigeria Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

Figure South Africa Prostate Cancer Medicine Revenue and Growth Rate (2013-2018)

Table Global Prostate Cancer Medicine Revenue (Million USD) by Type (2013-2018)

Table Global Prostate Cancer Medicine Revenue Share by Type (2013-2018)

Figure Global Prostate Cancer Medicine Revenue Share by Type (2013-2018)

Figure Global Prostate Cancer Medicine Revenue Share by Type in 2017

Table Global Prostate Cancer Medicine Revenue Forecast by Type (2018-2023)

Figure Global Prostate Cancer Medicine Market Share Forecast by Type (2018-2023)

Figure Global LHRH Antagonists Revenue Growth Rate (2013-2018)

Figure Global LHRH Analogs Revenue Growth Rate (2013-2018)

Figure Global Antiandrogens Revenue Growth Rate (2013-2018)

Figure Global Pipeline Drugs for Hormonal Therapy Revenue Growth Rate (2013-2018)

Table Global Prostate Cancer Medicine Revenue by Application (2013-2018)

Table Global Prostate Cancer Medicine Revenue Share by Application (2013-2018)

Figure Global Prostate Cancer Medicine Revenue Share by Application (2013-2018)

Figure Global Prostate Cancer Medicine Revenue Share by Application in 2017

Table Global Prostate Cancer Medicine Revenue Forecast by Application (2018-2023)

Figure Global Prostate Cancer Medicine Market Share Forecast by Application (2018-2023)

Figure Global Hospitals Revenue Growth Rate (2013-2018)

Figure Global Other Revenue Growth Rate (2013-2018)

Figure Global Prostate Cancer Medicine Revenue (Million USD) and Growth Rate Forecast (2018 -2023)

Table Global Prostate Cancer Medicine Revenue (Million USD) Forecast by Regions (2018-2023)

Figure Global Prostate Cancer Medicine Revenue Market Share Forecast by Regions (2018-2023)

Figure North America Prostate Cancer Medicine Revenue Market Forecast (2018-2023)

Figure Europe Prostate Cancer Medicine Revenue Market Forecast (2018-2023)

Figure Asia-Pacific Prostate Cancer Medicine Revenue Market Forecast (2018-2023)

Figure South America Prostate Cancer Medicine Revenue Market Forecast (2018-2023)

Figure Middle East and Africa Prostate Cancer Medicine Revenue Market Forecast (2018-2023)

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Companies

AstraZeneca plc

Active Biotech

Bristol Myers-Squibb

Teva Pharmaceuticals Industries Ltd.

Johnson & Johnson

Pfizer Inc.

Bayer AG

Abbott Laboratories

Astellas Pharma Inc.

Roche Holding AG